Submissions from 2013
Expressional alterations in functional ultra-conserved non-coding rnas in response to all-trans retinoic acid - induced differentiation in neuroblastoma cells., Karen M. Watters, Kenneth Bryan, Niamh H. Foley, Maria Meehan, and Raymond L. Stallings
Submissions from 2011
A 6-gene signature identifies four molecular subgroups of neuroblastoma., Frida Abel, Daniel Dalevi, Maria Nethander, Rebecka Jörnsten, Katleen De Preter, Joëlle Vermeulen, Raymond Stallings, Per Kogner, John Maris, and Staffan Nilsson
MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma., Amanda Tivnan, Lorraine Tracey, Patrick G. Buckley, Leah C. Alcock, Andrew M. Davidoff, and Raymond L. Stallings
Submissions from 2010
MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2., Niamh H. Foley, Isabella Bray, Amanda Tivnan, Kenneth Bryan, Derek M. Murphy, Patrick G. Buckley, Jacqueline Ryan, Anne O'Meara, Maureen O'Sullivan, and Raymond L. Stallings
Submissions from 2009
Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival., Isabella Bray, Kenneth Bryan, Suzanne Prenter, Patrick G. Buckley, Niamh H. Foley, Derek M. Murphy, Leah Alcock, Pieter Mestdagh, Jo Vandesompele, Frank Speleman, Wendy B. London, Patrick W. McGrady, Desmond G. Higgins, Anne O'Meara, Maureen O'Sullivan, and Raymond L. Stallings
Global MYCN transcription factor binding analysis in neuroblastoma reveals association with distinct E-box motifs and regions of DNA hypermethylation., Derek M. Murphy, Patrick G. Buckley, Kenneth Bryan, Sudipto Das, Leah Alcock, Niamh H. Foley, Suzanne Prenter, Isabella Bray, Karen M. Watters, Desmond Higgins, and Raymond L. Stallings